
PsychRounds: The Psychiatry Podcast
Dr. Tanner Hewitt, Dr. Larry Wang and Dr. Bradley MillerAudio
- Format:
- Podcast
- New episodes:
- Every two weeks
- Typical length:
- about 20 minutes
- Latest episode:
About this show
Welcome to Psych Rounds, the podcast tailored for psychiatry residents and students. Join us, three psychiatric resident physicians, as we delve into quick insights, interviews, and practical tips essential for educational practice. Subscribe for a straightforward yet informal approach to psychiatric knowledge.
Contact us: psychroundspodcast@gmail.com Instagram: https://www.instagram.com/psychrounds/
Covers: psychiatry, medical education, psychopharmacology, mental health, depression treatment, ADHD medication, antipsychotic drugs, addiction medicine, dsm diagnosis, clinical trials
Show details and episodes come from the publisher's public feed at anchor.fm. Last updated . Names, artwork and text belong to their publishers.
Recently on this show
Summary of recent episodes, drawn from the publisher's feed.
This podcast, made by psychiatry residents, is aimed at psychiatry trainees and students and offers quick insights, interviews and practical teaching tips. Recent episodes cover a validity-based diagnostic hierarchy, a new long-acting olanzapine injection, GLP-1 drugs in psychiatry, the STAR*D depression trial, and dogs and mental health.
Cosmos
Similar in subject
- Psychopharmacology and Psychiatry Updates
Both cover: addiction medicine, psychopharmacology, psychiatry - PMHNP Certification Q & A
Both cover: depression treatment, psychopharmacology, mental health - NEI Podcast
Both cover: psychopharmacology, psychiatry, mental health
Similar shows
Explore more
Episodes
Landmark Studies: STEP-BD
· 22 min
Welcome back! Our journal club continues... today we are going over the Systematic Treatment Enhancement Program for Bipolar Disorder, more commonly known as "STEP-BD". References: https://www.nejm.org/doi/full/10.1056/NEJMoa064135 (https://www.nejm.org/doi/full/10.1056/NEJMoa064135?utm_source=openevidence) https://pubmed.ncbi.nlm.nih.gov/12788248 https://onlinelibrary.wiley.com/doi/10.1111/j.1399-5618.2009.00715.x https://pubmed.ncbi.nlm.nih.gov/16449474/ https://pubmed.ncbi.nlm.nih.gov/20409444/
Not rated yetA Validity-Based Diagnostic Hierarchy with Dr. Mark Ruffalo and Dr. Ronald Pies
· 53 min
Today, we welcome back a former guest, Dr. Mark Ruffalo, and joining him is his colleague and co-author, Dr. Ronald Pies. We will be discussing their recently published article, The Need For A Validity-Based Hierarchy In DSM-6. Article: https://pubmed.ncbi.nlm.nih.gov/42908074/ Dr. Ruffalo Website: https://www.drruffalo.com/ Dr. Pies Psychiatric Times Profile: https://www.psychiatrictimes.com/authors/ronald-w-pies-md
Not rated yetA New Long-Acting Injectable: Olanzapine (Zyprexa) Weltruza
· 24 min
Today, we're covering the recent FDA approval of a new Olanzapine long-acting injectable - Weltruza. References: https://pubmed.ncbi.nlm.nih.gov/41632432/ https://pubmed.ncbi.nlm.nih.gov/42198294/ https://www.tevapharm.com/news-and-media/latest-news/new-long-term-safety-data-from-the-completed-phase-3-solaris-trial-support-the-potential-of-olanzapine-la/
Not rated yetPharmacogenetic Testing in Psychiatry
· 22 min
Welcome back, everyone! We’re back after PRITE, and today we’re discussing pharmacogenetic testing.
Not rated yetGLP-1 Agonists (Ozempic, Wegovy) in Psychiatry
· 32 min
Today, we will discuss GLP-1's and the emerging use of this class of medications in psychiatry. Sources: https://pubmed.ncbi.nlm.nih.gov/42247271/ https://pmc.ncbi.nlm.nih.gov/articles/PMC11441540/ https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2838205 (https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2838205?utm_source=openevidence&utm_medium=referral) https://pubmed.ncbi.nlm.nih.gov/42070571 https://pubmed.ncbi.nlm.nih.gov/41806782/
Not rated yetLandmark Studies: The STAR*D Trial
· 28 min
We resume our landmark studies series looking at the pivotal study in Major Depressive Disorder (MDD), The STAR*D (Sequenced Treatment Alternatives to Relieve Depression) trial. References: https://pubmed.ncbi.nlm.nih.gov/12778843/ https://pubmed.ncbi.nlm.nih.gov/19880458/ https://jamanetwork.com/journals/jamapsychiatry/fullarticle/482026 (https://jamanetwork.com/journals/jamapsychiatry/fullarticle/482026?utm_source=openevidence&utm_medium=referral) https://pubmed.ncbi.nlm.nih.gov/15061154/ https://pubmed.ncbi.nlm.nih.gov/20370962/ https://pubmed.ncbi.nlm.nih.gov/37491091/
Not rated yetDogs in Mental Health with Dr. Nancy Gee: A Biopsychosocial Approach
· 54 min
We have a special guest today to talk about one of our favorite topics... dogs! Most people might intuitively say that they feel like their dogs improve their mental health, but today, we look at the science with the leading expert on the subject. Dr. Nancy Gee Profile: https://medschool.vcu.edu/about/portfolio/details/geen2/ References: Dogs Supporting Human Health and Well-Being: A Biopsychosocial Approach: https://pubmed.ncbi.nlm.nih.gov/33860004/ Randomized Controlled Trials: https://pmc.ncbi.nlm.nih.gov/articles/PMC12728353/, https://pmc.ncbi.nlm.nih.gov/articles/PMC11714157/
Not rated yetCentanafadine (Simtriyo): A New Medication for ADHD
· 28 min
Welcome back! Today, we are talking about Simtriyo, which has generated a lot of media attention recently given a newly minted FDA approval for ADHD. References https://pmc.ncbi.nlm.nih.gov/articles/PMC12314114/ https://pmc.ncbi.nlm.nih.gov/articles/PMC12379780/ https://pubmed.ncbi.nlm.nih.gov/31776871/ https://pubmed.ncbi.nlm.nih.gov/40619095/ https://pubmed.ncbi.nlm.nih.gov/28731336/ https://pmc.ncbi.nlm.nih.gov/articles/PMC9426730/
Not rated yetLandmark Studies: The CATIE Trial
· 21 min
Today we're starting a new type of series - looking at some of the most seminal studies in psychiatry. We're going to start with the CATIE Trial, which was published in 2005. References: https://www.nejm.org/doi/full/10.1056/NEJMoa051688 (https://www.nejm.org/doi/full/10.1056/NEJMoa051688?utm_source=openevidence) https://pubmed.ncbi.nlm.nih.gov/19594194/ https://pubmed.ncbi.nlm.nih.gov/17924259/ https://pubmed.ncbi.nlm.nih.gov/17286522/ https://www.nejm.org/doi/full/10.1056/NEJMoa061240 (https://www.nejm.org/doi/full/10.1056/NEJMoa061240?utm_source=openevidence) https://jamanetwork.com/journals/jamapsychiatry/fullarticle/209844
Not rated yetThe Rising Use of Recreational Kratom
· 21 min
Apologies for our little hiatus - a couple of us had cross-country moves in June. But we're back! Today we have an episode on the rising use of recreational Kratom and pertinent tidbits to know from a psychiatry standpoint. References: - https://pmc.ncbi.nlm.nih.gov/articles/PMC8924421/ - https://www.ncbi.nlm.nih.gov/books/NBK585120/ - https://pmc.ncbi.nlm.nih.gov/articles/PMC10846393/ - https://pmc.ncbi.nlm.nih.gov/articles/PMC10177737/
Not rated yetModafinil (Provigil)
· 19 min
Welcome back! Today, we are looking at Modafinil and it's nuanced use in psychiatry. References: - Provigil (modafinil) [prescribing information]. North Wales, PA: Teva Pharmaceuticals USA, Inc. U.S. Food and Drug Administration. Available at: https://www.accessdata.fda.gov/drugsatfdadocs/label/2015/020717s037s038lbl.pdf - Schwartz JR. Modafinil in the treatment of excessive sleepiness. Drug Des Devel Ther. 2009;2:71–85. - Kaplan S, Goehring EL Jr, Engel T, et al. Cardiovascular outcomes associated with modafinil in patients with obstructive sleep apnea. Pharmacoepidemiol Drug Saf. 2018;27(11):1182–1190. doi:10.1002/pds.4642 - Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727–738. doi:10.1016/S2215-0366(18)30269-4 - Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CH. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry. 2013;74(11):1101–1107. doi:10.4088/JCP.13r08560 - Bahji A, Mesbah-Oskui L. Comparative efficacy and safety of stimulant-type medications for depression: a systematic review and network meta-analysis. J Affect Disord. 2021;292:416–423. doi:10.1016/j.jad.2021.05.119 - Nunez NA, Singh B, Jorgensen A, et al. Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: a meta-analysis of randomized controlled trials. Bipolar Disord. 2020;22(2):109–120. doi:10.1111/bdi.12859
Not rated yetNaltrexone
· 16 min
Welcome Back! Today we are discussing the medication Naltrexone and its uses in psychiatry. References: - https://www.ncbi.nlm.nih.gov/books/NBK534811/ - https://pubmed.ncbi.nlm.nih.gov/24825644/ - https://pubmed.ncbi.nlm.nih.gov/26798982/ - https://www.nejm.org/doi/full/10.1056/NEJMct0801733 (https://www.nejm.org/doi/full/10.1056/NEJMct0801733?utm_source=openevidence) - https://pubmed.ncbi.nlm.nih.gov/26798982/
Not rated yetPlacebo Effect and Response in Psychiatry
· 22 min
Welcome back! Today, we will be discussing the placebo effect. References: https://pubmed.ncbi.nlm.nih.gov/16503356/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003660/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556377/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714297/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694178 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694178/#:~:text=Several%20mechanisms%20have%20been%20described,the%20treatment%20provider%20(24))/ https://www.psychiatrypodcast.com/psychiatry-psychotherapy-podcast/2018/11/19/understanding-placebo
Not rated yetAmantadine (Symmetrel)
· 17 min
Welcome back! Today we are talking all about Amantadine, and it's uses in psychiatry.
Not rated yetVMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)
· 17 min
Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo). References: https://pubmed.ncbi.nlm.nih.gov/41626799/ https://www.ncbi.nlm.nih.gov/books/NBK548187/ https://pubmed.ncbi.nlm.nih.gov/41626799/
Not rated yetA DSM Conversation with Dr. Allen Frances
· 55 min
We are back with another special guest episode! Please welcome Dr. Allen Frances, who was intricately involved in the formation of both the DSM III and DSM IV, the latter of which he served as chair. https://x.com/AllenFrancesMD https://www.amazon.com/stores/author/B001HO76FU https://www.psychiatrictimes.com/authors/allen-frances-md
Not rated yetTopiramate (Topamax)
· 15 min
Welcome back! Today we will be doing a brief episode on Topiramate [Topamax], and its clinical uses in psychiatry. References: - https://pubmed.ncbi.nlm.nih.gov/21438989/ - https://pubmed.ncbi.nlm.nih.gov/18774432/ - https://pubmed.ncbi.nlm.nih.gov/25899459/ - https://pmc.ncbi.nlm.nih.gov/articles/PMC1088011/ - https://pmc.ncbi.nlm.nih.gov/articles/PMC2671954/ - https://pubmed.ncbi.nlm.nih.gov/38706338/ - https://pubmed.ncbi.nlm.nih.gov/20207521/
Not rated yetWhat Makes Something a Psychiatric Illness? Featuring Dr. Mark Ruffalo, MSW, DPsa
· 54 min
Welcome back, today we are discussing a deceptively difficult topic: What makes something a psychiatric illness? We are joined by our guest Dr. Mark Ruffalo. He is a psychotherapist in private practice in Tampa, FL, and who also serves as Assistant Professor of Psychiatry at the University of Central Florida College of Medicine as well an Adjunct Assistant Professor of Psychiatry at Tufts University School of Medicine. Dr. Ruffalo's Website: https://www.drruffalo.com/ Dr. Ruffalo's LinkedIn: https://www.linkedin.com/in/mark-l-ruffalo-71929063 PRISM: https://www.psychiatrictimes.com/view/use-of-the-prism-diagnostic-instrument-in-clinical-practice PRISM Writing Contest: https://www.psychiatrictimes.com/view/prism-writing-contest-more-on-this-new-diagnostic-tool-from-mark-ruffalo-msw-dpsa
Not rated yetLorazepam (Ativan)
· 14 min
Welcome back! Today we are at the highly prescribed and popular benzodiazepine Lorazepam, also known as Ativan. We look at its uses in psychiatry, especially catatonia. But despite anecdotal efficacy, does the evidence hold up? References: - https://www.ncbi.nlm.nih.gov/books/NBK532890/ - https://pubmed.ncbi.nlm.nih.gov/36805317/ - https://pubmed.ncbi.nlm.nih.gov/6120058/ - https://pubmed.ncbi.nlm.nih.gov/10229064/ - https://psychopharmacologyinstitute.com/section/catatonia-diagnosis-the-lorazepam-challenge-2911-5899/
Not rated yetThe Vitamin Series: Iron Deficiency in Psychiatry
· 25 min
Welcome back! Today we are embarking into the first of hopefully several episodes on the importance of vitamins and minerals in mental health. We will specifically be looking at the role of iron deficiency in psychiatry and do an overview on some of the recent research that's been published. References: - https://www.ncbi.nlm.nih.gov/books/NBK557376/ - https://www.sciencedirect.com/science/article/pii/S0268960X25000827#bb0165 - https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2823909 - https://www.sciencedirect.com/science/article/pii/S1389945717315599 - https://pubmed.ncbi.nlm.nih.gov/40841680/ - https://pubmed.ncbi.nlm.nih.gov/1677067/ - https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00463-7/fulltext - https://pmc.ncbi.nlm.nih.gov/articles/PMC6139360/
Not rated yet